Category Archives: Clinical Cardiology

Heart disease is the Number 1 killer in the United States. Too few people covered by Medicare participated in outpatient cardiac rehabilitation after a heart attack or acute heart event or surgery, particularly women, the elderly and non-white patients, according to new research published today in the American Heart Associations journalCirculation: Cardiovascular Quality and Outcomes. Every year, an estimated 1.3 million U.S. Continue reading →

Yinghui Shang, 1 Qinghai Wang, 2 Jian Li, 1 Qiangqiang Zhao, 1 Xueyuan Huang, 1 Hang Dong, 1 Haiting Liu, 1 Ye Zhang, 3 Junhua Zhang, 1 Rong Gui, 1 Xinmin Nie 4 1Department of Blood Transfusion, The Third Xiangya Hospital, Central South University, Changsha, Peoples Republic of China; 2Department of Cardiology, The Second Hospital of Shandong University, Jinan, Peoples Republic of China; 3Department of Cell Biology, School of Basic Medicine, Peking University, Beijing, Peoples Republic of China; 4Clinical Laboratory of the Third Xiangya Hospital, Central South University, Changsha, Peoples Republic of China Correspondence: Rong Gui Department of Blood Transfusion, The Third Xiangya Hospital, Central South University, No. Continue reading →

Key Companies Covered in the Examination Lights Market Research Report are Dr. Mach GmbH & Co. KG, Technomed India, Steris plc., Stryker, Skytron, LLC, SIMEON Medical GmbH & Co. Continue reading →

Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market, has announced that its WatchPAT has been selected for inclusion in the Weizmann Institutes Project 10K. One of the largest projects of its kind, the 10K Project is a longitudinal study designed to collect lifestyle and clinical data from 10,000 individuals over ten years and aims to use state-of-the-art artificial intelligence technologies to analyze the data in order to generate personalized predictions for disease risk factors Continue reading →

Diastolic blood pressure and resting heart rate provide important prognostic information for patients with hemodynamically significant chronic aortic regurgitation (AR), new data show. Diastolic readings below 70 mm Hg and resting heart rates above 60 beats per minute (bpm) were strongly associated with all-cause mortality in medically managed patients, even after accounting for potential confounders like hypertension, use of various medications, and guideline indications for valve surgery, lead author Li-Tan Yang, MD (Mayo Clinic, Rochester, MN), and colleagues report Continue reading →

14Jan2020 Revian phototherapy device promotes generation and release of nitric oxide. The company is developing Revian Red, a wearable cap controlled by a smartphone app, which a patient wears for a few minutes each day Continue reading →

Fish oil supplements for cardiovascular (CV) protection have been a controversial topic for years. Recently, Vascepa (Amarin), a prescription fish oil comprising high-dose icosapent ethyl, received an expanded indication from the US Food and Drug Administration (FDA) for CV risk reduction in some patients with elevated triglyceride (TG) levels Continue reading →

Accountable care organizations (ACOs), a byproduct of the Affordable Care Act (ACA), were designed and deployed to better coordinate and manage the delivery of care and reduce healthcare costs to the system. Theoretically ACOs are built to manage patients on the care continuum to ensure that care is coordinated to deliver quality outcomes and better, lower-cost care. Continue reading →

A multidisciplinary clinical and social intervention program aimed at patients deemedto be "superutilizers" of the healthcare system failed to make a difference in 180-day readmission rates in a randomized, controlled trial. The study casts some doubt on whether such "hotspotting" might have promise as a way to reduce burgeoning US healthcare costs, as has been hoped. The term refers to a process of predicting, identifying, and addressing the needs of superutilizers to improve their health outcomes and lessen their use of healthcare resources. Continue reading →

Promising results were observed in a small, prospective study published in JAMA, in which patients with chemotherapy-induced cardiomyopathy (CHIC) were treated with cardiac resynchronization therapy (CRT).1 Certain cytotoxic agents, especially anthracyclines, as well as other anticancer treatments such as some monoclonal antibodies and tyrosine kinase inhibitors, are associated with an increased risk of cardiomyopathy. Termed CHIC, this progressive condition is believed to be due to drug-related myocyte death, resulting in ventricular remodeling, and ultimately leading to heart failure Continue reading →